A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in is favor in a patent dispute with Medtronic ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...